HK1158066A1 - A polypeptide for use in treating dengue virus infections - Google Patents
A polypeptide for use in treating dengue virus infectionsInfo
- Publication number
- HK1158066A1 HK1158066A1 HK11112416.8A HK11112416A HK1158066A1 HK 1158066 A1 HK1158066 A1 HK 1158066A1 HK 11112416 A HK11112416 A HK 11112416A HK 1158066 A1 HK1158066 A1 HK 1158066A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- polypeptide
- dengue virus
- virus infections
- treating dengue
- treating
- Prior art date
Links
- 206010012310 Dengue fever Diseases 0.000 title 1
- 208000025729 dengue disease Diseases 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8194308P | 2008-07-18 | 2008-07-18 | |
| PCT/US2009/050966 WO2010009380A2 (fr) | 2008-07-18 | 2009-07-17 | Procédés pour traiter des infections de la dengue à médiation immune, et amélioration dépendant d'anticorps d'infections de la dengue, y compris une fièvre hémorragiques de dengue et un syndrome de choc de la dengue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1158066A1 true HK1158066A1 (en) | 2012-07-13 |
Family
ID=41551029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK11112416.8A HK1158066A1 (en) | 2008-07-18 | 2011-11-17 | A polypeptide for use in treating dengue virus infections |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8815813B2 (fr) |
| EP (1) | EP2320924B1 (fr) |
| JP (1) | JP5806112B2 (fr) |
| CN (1) | CN102159231B (fr) |
| AU (2) | AU2009270805B2 (fr) |
| BR (1) | BRPI0915968B1 (fr) |
| CA (1) | CA2731218A1 (fr) |
| HK (1) | HK1158066A1 (fr) |
| HR (1) | HRP20150620T1 (fr) |
| IL (1) | IL210717A (fr) |
| MX (1) | MX2011000647A (fr) |
| MY (1) | MY160699A (fr) |
| SG (1) | SG10201500597YA (fr) |
| WO (1) | WO2010009380A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2559887C (fr) | 2004-03-10 | 2018-12-04 | Trinity Therapeutics, Inc. | Procede d'inhibition de formation de complexes immuns chez un sujet |
| AU2009270805B2 (en) | 2008-07-18 | 2016-11-03 | Trinity Therapeutics, Inc. | Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| WO2016106342A2 (fr) * | 2014-12-22 | 2016-06-30 | Middle Tennessee State University | Méthodes destinées à traiter les infections virales à médiation immunitaire |
| US10227383B2 (en) * | 2015-05-20 | 2019-03-12 | Kagoshima University | Specific modification of antibody with IgG-binding peptide |
| WO2017189891A1 (fr) * | 2016-04-27 | 2017-11-02 | Middle Tennessee State University | Méthodes de traitement d'infections par le virus zika et de complications associées |
| CN115804362A (zh) * | 2023-02-08 | 2023-03-17 | 中国医学科学院医学生物学研究所 | 一种IFN-α/βR-/-小鼠抗体依赖性增强感染的注射液及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189014A (en) | 1979-12-03 | 1993-02-23 | Cowan Jr Fred M | Method of treating cellular Fc receptor mediated hypersensitivity immune disorders |
| US4383317A (en) | 1980-10-30 | 1983-05-10 | Bei Electronics, Inc. | Shaft angle encoder having a circuit for synthesizing a skipped track output signal |
| IT1190891B (it) | 1982-06-24 | 1988-02-24 | Anic Spa | Metodo per la sintesi in fase solida di polipeptidi retroinvertiti |
| US5693758A (en) | 1987-11-19 | 1997-12-02 | 501 Research Corporation Limited | Immunoglobulin E competitor |
| US5932483A (en) | 1990-10-16 | 1999-08-03 | Northwestern University | Synthetic peptide and its uses |
| DK0590058T3 (da) | 1991-06-14 | 2004-03-29 | Genentech Inc | Humaniseret heregulin-antistof |
| US6420127B1 (en) | 1994-11-18 | 2002-07-16 | Washington University | Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| EP0894002A4 (fr) | 1996-03-13 | 2001-11-14 | Univ Pennsylvania | Nouveaux peptides inhibant l'activation du complement |
| ITMI962628A1 (it) | 1996-12-16 | 1998-06-16 | Tecnogen Scpa | Composizione farmaceutica |
| EP1109545A4 (fr) | 1998-09-11 | 2004-11-10 | Ilexus Pty Ltd | MODULATEURS DU RECEPTEUR Fc ET UTILISATION DE CES MODULATEURS |
| US20030190740A1 (en) | 1998-10-13 | 2003-10-09 | The University Of Georgia Research Foundation, Inc | Stabilized bioactive peptides and methods of identification, synthesis, and use |
| AU773428B2 (en) | 1998-10-13 | 2004-05-27 | Peptide Biosciences, Inc. | Stabilized bioactive peptides and methods of identification, synthesis and use |
| EP1240337B1 (fr) | 1999-12-24 | 2006-08-23 | Genentech, Inc. | Methodes et compositions permettant de prolonger les demi-vies d'elimination de composes bioactifs |
| AU2002217010A1 (en) | 2000-11-08 | 2002-05-21 | Affina Immuntechnik Gmbh | Peptides, the production and use thereof for binding immunoglobulins |
| US6916904B2 (en) | 2002-04-24 | 2005-07-12 | Zolaris Biosciences, Llc | Inhibition of immune complex formation |
| NZ536963A (en) | 2002-06-07 | 2008-04-30 | Trillium Therapeutics Inc | Use of the discovery that Fc gamma receptor IIA transgenic animals are susceptible to autoimmune disease, to suppress aberrant immune activity and to treat or prevent autoimmune disease |
| AU2002953533A0 (en) | 2002-12-24 | 2003-01-16 | Arthron Limited | Fc receptor modulating compounds and compositions |
| CA2559887C (fr) | 2004-03-10 | 2018-12-04 | Trinity Therapeutics, Inc. | Procede d'inhibition de formation de complexes immuns chez un sujet |
| KR20130048793A (ko) | 2004-08-12 | 2013-05-10 | 헬신 세라퓨틱스 (유.에스.) 인크. | 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을 촉진하는 방법 |
| CN101277714B (zh) | 2005-09-06 | 2013-01-30 | 三一治疗公司 | 治疗免疫介导的神经疾病的方法 |
| EP1960427B1 (fr) | 2005-12-13 | 2011-02-23 | SuppreMol GmbH | Polypeptides polymeres pour recepteurs fc |
| US20120021988A1 (en) | 2007-08-14 | 2012-01-26 | Bodie Neil M | Methods for treating immune thrombocytopenia |
| AU2009270805B2 (en) | 2008-07-18 | 2016-11-03 | Trinity Therapeutics, Inc. | Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
-
2009
- 2009-07-17 AU AU2009270805A patent/AU2009270805B2/en not_active Ceased
- 2009-07-17 US US13/054,738 patent/US8815813B2/en not_active Expired - Fee Related
- 2009-07-17 WO PCT/US2009/050966 patent/WO2010009380A2/fr active Application Filing
- 2009-07-17 MX MX2011000647A patent/MX2011000647A/es active IP Right Grant
- 2009-07-17 JP JP2011518930A patent/JP5806112B2/ja not_active Expired - Fee Related
- 2009-07-17 MY MYPI2011000225A patent/MY160699A/en unknown
- 2009-07-17 CN CN200980136119.9A patent/CN102159231B/zh not_active Expired - Fee Related
- 2009-07-17 EP EP09798797.8A patent/EP2320924B1/fr active Active
- 2009-07-17 SG SG10201500597YA patent/SG10201500597YA/en unknown
- 2009-07-17 BR BRPI0915968-1A patent/BRPI0915968B1/pt not_active IP Right Cessation
- 2009-07-17 CA CA2731218A patent/CA2731218A1/fr not_active Abandoned
-
2011
- 2011-01-18 IL IL210717A patent/IL210717A/en active IP Right Grant
- 2011-11-17 HK HK11112416.8A patent/HK1158066A1/xx not_active IP Right Cessation
-
2015
- 2015-06-10 HR HRP20150620TT patent/HRP20150620T1/hr unknown
-
2017
- 2017-02-03 AU AU2017200760A patent/AU2017200760A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009270805B2 (en) | 2016-11-03 |
| AU2009270805A1 (en) | 2010-01-21 |
| CN102159231B (zh) | 2016-06-15 |
| US8815813B2 (en) | 2014-08-26 |
| WO2010009380A2 (fr) | 2010-01-21 |
| WO2010009380A9 (fr) | 2010-04-08 |
| EP2320924A4 (fr) | 2012-07-25 |
| IL210717A0 (en) | 2011-03-31 |
| JP2011528665A (ja) | 2011-11-24 |
| CA2731218A1 (fr) | 2010-01-21 |
| IL210717A (en) | 2017-07-31 |
| EP2320924B1 (fr) | 2015-03-11 |
| AU2017200760A1 (en) | 2017-03-02 |
| MX2011000647A (es) | 2011-09-29 |
| HRP20150620T1 (en) | 2015-09-25 |
| US20110218157A1 (en) | 2011-09-08 |
| SG10201500597YA (en) | 2015-04-29 |
| EP2320924A1 (fr) | 2011-05-18 |
| JP5806112B2 (ja) | 2015-11-10 |
| BRPI0915968B1 (pt) | 2021-11-23 |
| MY160699A (en) | 2017-03-15 |
| CN102159231A (zh) | 2011-08-17 |
| BRPI0915968A2 (pt) | 2020-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250936A1 (zh) | 用於治療病毒感染的化合物和方法 | |
| PL2310034T3 (pl) | Peptydy do leczenia beta-amyloidoz | |
| HRP20150620T1 (en) | A polypeptide for use in treating dengue virus infections | |
| ZA201107521B (en) | 4 -cyano- 3 -benzoylamino-n-phenyl-benzamides for use in pest control | |
| EP2298801A4 (fr) | Peptide glp-1 glycosylé | |
| HK1223946A1 (zh) | 生物活性肽 | |
| ZA201008295B (en) | Improvements in feedwells | |
| DK2268666T3 (da) | Rekombinant FSH indbefattende alpha-2,3- og alpha-2,6-sialylering | |
| IL217562A0 (en) | Treatment with alpha 7-selective ligands | |
| DK2352876T3 (da) | Behandlet tekstilmateriale til anvendelse i vandige miljøer | |
| GB0920981D0 (en) | Peptides | |
| ZA201100019B (en) | Variant hhip1 protein and methods and uses thereof | |
| EP2285827A4 (fr) | Peptides et leurs utilisations | |
| EP2358740A4 (fr) | Peptides cycliques et leurs utilisations | |
| GB0807870D0 (en) | Improvements in actuators | |
| GB0920987D0 (en) | Peptides | |
| GB0823560D0 (en) | Virus | |
| GB0817978D0 (en) | Peptides | |
| GB0823515D0 (en) | Improvements in bivvies | |
| EP2195338A4 (fr) | Interféron-alpha modifié n-terminal | |
| GB0816561D0 (en) | Peptides and uses thereof | |
| GB0813823D0 (en) | Virus | |
| GB0810378D0 (en) | Virus | |
| GB0810449D0 (en) | Peptides | |
| GB0815673D0 (en) | Peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210714 |